Biological Treatments of OCD (AQA A-Level Psychology): Revision Notes
Biological Treatments of OCD
Introduction to drug therapy
Biological explanations of OCD suggest that abnormal neurotransmitter levels contribute to the disorder, making drug treatments a logical therapeutic approach. Drug therapy refers to treatment using chemicals that affect brain functioning or other body systems, particularly by altering neurotransmitter levels in psychological disorders.
Since research indicates that low serotonin levels are associated with OCD, drug treatments focus on increasing serotonin availability in the brain through various mechanisms. This biological approach targets the underlying neurochemical imbalances rather than just managing symptoms.
Selective serotonin reuptake inhibitors (SSRIs)
SSRIs (Selective Serotonin Reuptake Inhibitors) represent the standard medical treatment for OCD symptoms. These antidepressant medications specifically target the serotonin system in the brain.
How SSRIs work
Serotonin is released by presynaptic neurons and travels across synapses to communicate with postsynaptic neurons. Normally, serotonin is then reabsorbed by the presynaptic neuron, where it breaks down and becomes reused.
How SSRI Mechanism Works:
Step 1: Serotonin is released by presynaptic neurons into the synaptic gap Step 2: SSRIs block the reuptake process, preventing serotonin reabsorption Step 3: Serotonin levels increase in the synaptic gap Step 4: Enhanced stimulation of postsynaptic neurons compensates for serotonin dysfunction in OCD
SSRIs work by blocking this reuptake process, effectively increasing serotonin levels in the synaptic gap and continuing to stimulate the postsynaptic neuron. This mechanism compensates for whatever dysfunction exists in the serotonin system in OCD.
Dosage and administration
A typical daily dose of Fluoxetine (commonly known as Prozac) is 20mg, though this may be increased if the patient shows insufficient improvement. The medication is available in both capsule and liquid forms.
SSRIs require consistent daily use for three to four months before showing significant impact on symptoms. This is a crucial timeframe that patients and healthcare providers must understand - immediate effects should not be expected.
Combining SSRIs with other treatments
Drug treatments are frequently used alongside Cognitive Behavioural Therapy (CBT) to treat OCD. The medication helps reduce emotional symptoms such as anxiety and depression, enabling patients to engage more effectively with psychological therapy. Individual responses vary considerably - some patients respond best to CBT alone, whilst others benefit more from medications like Fluoxetine. Occasionally, additional drugs are prescribed alongside SSRIs.
Alternatives to SSRIs
When SSRIs prove ineffective after three to four months, several alternatives exist:
Dose adjustment and combinations
The SSRI dose can be increased (for example, up to 60mg daily for Fluoxetine) or combined with other medications.
Patient responses to different drugs vary significantly, and alternatives work well for some individuals whilst proving ineffective for others. This highlights the importance of personalised treatment approaches in OCD management.
Tricyclics
Tricyclics represent an older class of antidepressants sometimes used for OCD treatment. Clomipramine is a notable example that affects the serotonin system similarly to SSRIs. However, Clomipramine produces more severe side effects than SSRIs, so it's typically reserved for patients who don't respond to first-line treatments.
SNRIs
SNRIs (Serotonin-Noradrenaline Reuptake Inhibitors) represent a newer drug class that has gained use in OCD treatment over the past five years. Like Clomipramine, SNRIs serve as second-line treatments for patients unresponsive to SSRIs. These medications increase both serotonin and noradrenaline levels, providing a different neurochemical approach.
Evaluation
Drug therapy demonstrates effectiveness
Substantial evidence supports SSRI effectiveness in reducing OCD symptom severity and improving patient quality of life. Soomro et al. (2009) conducted a comprehensive review comparing SSRIs to placebos in OCD treatment, finding that all 17 reviewed studies showed significantly superior results for SSRIs compared to placebo conditions. The research indicates greatest effectiveness when SSRIs combine with psychological treatments, particularly CBT.
Approximately 70% of patients taking SSRIs experience significant symptom decline. For the remaining 30%, alternative drug treatments or combinations of medications and psychological therapies prove effective for some individuals. This suggests that drug treatments can help the majority of OCD patients.
Cost-effectiveness and accessibility
Drug treatments offer considerable advantages in terms of cost compared to psychological therapies, making them valuable for public health systems like the NHS. SSRIs are also non-disruptive to patients' lives - individuals can simply take medication until symptoms improve without engaging in the demanding work required by psychological therapy approaches.
Many healthcare providers and patients favour drug treatments for these practical reasons.
Side effects present limitations
Although SSRIs often help OCD sufferers, a significant minority experience no benefit. Some patients suffer side effects including indigestion, blurred vision, and reduced sex drive. These side effects are typically temporary.
Clomipramine Side Effects Are More Serious:
- More than 10% of patients experience erectile dysfunction, tremors, and weight gain
- Over 1% become aggressive and suffer blood pressure and heart rhythm disruptions
- Such adverse effects reduce treatment effectiveness because people discontinue medication
Research bias concerns
Despite SSRIs' general effectiveness and short-term side effects, drug treatments face some controversy. Some psychologists argue that evidence favouring drug treatments contains bias because pharmaceutical companies sponsor the research and may not report all findings. This suggests that effectiveness data may lack complete trustworthiness, as companies might suppress results that don't support their marketed drugs.
Appropriateness for trauma-related cases
OCD is widely considered biological in origin, supporting the logic of biological treatments as standard practice. However, OCD can have various causes, and some cases develop following traumatic life events.
There's debate about whether cases with family history but no trauma should receive different treatment approaches than those with relevant life events but no family history. Cases with family history but no trauma history appear more clearly biological in origin, making drug treatment more obviously appropriate.
However, no clear evidence suggests that drugs are less effective or psychological therapies more effective for trauma-related OCD cases. This raises questions about whether drug treatments are being applied indiscriminately across different OCD presentations.
Key Points to Remember:
- SSRIs work by blocking serotonin reuptake, increasing neurotransmitter levels in brain synapses to compensate for dysfunction in OCD
- Treatment takes time - SSRIs require 3-4 months of consistent daily use before showing significant symptom improvement
- Combination approaches are most effective - SSRIs work best when paired with psychological therapies like CBT
- Multiple options exist for non-responders - tricyclics and SNRIs provide alternative treatments when SSRIs prove ineffective
- Evidence supports effectiveness but has limitations - strong research evidence exists, though concerns about pharmaceutical company bias and appropriateness for different OCD causes remain valid considerations